Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
+ND Capital, formerly known as NanoDimension, is a venture capital firm founded in 2002. The firm operates from offices in the United States, Switzerland, and the Cayman Islands, focusing on investments in disruptive technologies across the life, physical, and data sciences. Currently, +ND Capital manages approximately $500 million in assets across multiple funds, including its latest Fund III, which has a size of $335 million. This firm has established a strong presence in the venture capital landscape over its two-decade history.
+ND Capital's investment strategy is rooted in the belief that the convergence of scientific disciplines will lead to significant breakthroughs. The firm has evolved from its original focus on nanotechnology to a broader scope that includes various sectors such as biotech, healthcare, AI, fintech, energy, and proptech. Notable milestones include successful exits from companies like ARMO Biosciences, Serotiny, and Icosavax, showcasing the firm's ability to identify and nurture high-potential startups.
+ND Capital invests primarily in the life sciences and physical sciences sectors, targeting companies that are developing disruptive technologies. The firm operates in both the United States and Europe, leveraging its teams located in Silicon Valley, Switzerland, and the Cayman Islands. This geographic diversity allows +ND Capital to assist portfolio companies in attracting capital, talent, and business partners effectively.
The firm typically invests at the seed and Series B stages, focusing on companies that align with its thesis of scientific convergence. Investment checks generally range from $1 million to $10 million, depending on the specific needs of the portfolio company. +ND Capital seeks founders who demonstrate a strong vision and the capability to execute their business plans, particularly in sectors such as healthcare services, B2B software, transportation, AI, and deep tech.
+ND Capital's active portfolio includes several notable companies:
Additionally, the firm has a strong track record of successful exits, including:
This diverse portfolio reflects +ND Capital's commitment to investing in innovative technologies that have the potential to disrupt their respective industries.
Aymeric Sallin: Founder & Chief Executive Officer. Aymeric has extensive experience in venture capital and technology investments, having led numerous successful funding rounds and exits.
Eric Moessinger: Partner. Eric brings a wealth of knowledge in the life sciences sector, with a focus on identifying high-potential startups.
Kirill Kuzmichev: Principal. Kirill specializes in deep tech investments and has a strong background in engineering and technology commercialization.
Peter Liddiard: Chief Operating Officer & Chief Financial Officer. Peter oversees the firm's operations and financial strategy, ensuring efficient management of assets.
Jonathan Nicholson: Executive Director of the General Partner. Jonathan plays a key role in strategic decision-making and portfolio management.
Richard Coles: Director of the General Partner. Richard focuses on business development and partnership opportunities for portfolio companies.
Alison Palmer: Vice President of the General Partner. Alison supports investment analysis and portfolio management, contributing to the firm's strategic initiatives.
To pitch to +ND Capital, founders should utilize the preferred channel of their website at nd.capital or send an email to info@nd.capital. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and team qualifications. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In recent months, +ND Capital has made significant strides in its investment activities. The firm has continued to expand its portfolio, focusing on companies that align with its thesis of scientific convergence. Notable investments include several startups in the biotech and AI sectors, reflecting the firm's commitment to disruptive technologies.
Additionally, +ND Capital has successfully facilitated exits for several portfolio companies, including ARMO Biosciences, which was acquired by Pfizer, and Serotiny, acquired by Johnson & Johnson. These exits highlight the firm's ability to identify and nurture high-potential startups.
As of late 2023, +ND Capital is actively raising its next fund, aiming to build on its successful track record and further support innovative companies across North America and Europe.
What are +ND Capital's investment criteria?
+ND Capital focuses on investing in disruptive technologies across various sectors, particularly in life sciences and physical sciences. The firm typically invests at the seed and Series B stages, looking for companies that demonstrate strong growth potential and innovative solutions.
How can founders apply or pitch to +ND Capital?
Founders can pitch to +ND Capital through their website at nd.capital or by emailing their pitch deck to info@nd.capital. It is advisable to include a clear business model, market analysis, and team background in the pitch.
What makes +ND Capital different from other venture firms?
+ND Capital emphasizes the convergence of scientific disciplines, which allows them to identify unique investment opportunities that others may overlook. Their strong presence in both the U.S. and European markets also provides a competitive advantage in attracting talent and capital.
What is the geographic scope of +ND Capital's investments?
The firm primarily invests in North America and Europe, leveraging its teams in Silicon Valley, Switzerland, and the Cayman Islands to support portfolio companies.
What is the typical check size for investments?
+ND Capital typically invests between $1 million and $10 million, depending on the specific needs and growth stage of the portfolio company.
How involved is +ND Capital post-investment?
+ND Capital provides strategic support to its portfolio companies, leveraging its extensive network to help them attract capital, talent, and business partners, facilitating their growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.